The gut health category is crowded: How can brands truly stand out?

For formulators, the challenge is no longer simply finding a gut health ingredient, but a product that provides the credible science, relevant benefits and the flexibility to support innovative product formats


Substantiation matters

Broad microbiome or ingredient-level claims can tell only part of the story. Human clinical research provides a stronger foundation for understanding whether an ingredient can deliver a meaningful benefit, at an appropriate dose and to a relevant cohort. For brands, this distinction can have strong commercial value. 

Bimuno GOS from Clasado is supported by more than 135 scientific publications and 25 clinical studies, with more than 100 available health claims across multiple global markets. The portfolio spans gastrointestinal, immune and brain health, giving formulators a substantial evidence base from which to develop differentiated products and communicate benefits in line with market requirements.

In a crowded gut health market, meaningful differentiation comes from scientific substantiation, not speculation.

The benefits of lower inclusion levels in formulations 

The gut health category is crowded: How can brands truly stand out?

Consumers expect convenient products that fit easily into everyday routines, while formulators need flexibility across capsules, tablets, beverages and other delivery formats. Inclusion level is therefore an important part of product development. 

Recent peer-reviewed research found that Bimuno GOS produces a statistically significant bifidogenic effect from just 500 mg of Bimuno powder per day. The finding adds to the formulation flexibility offered by the ingredient, particularly where space is limited, while its established applications can be considered at appropriate doses for specific health outcomes. 

Ingredients proven to work at lower inclusion levels may also help brands optimise cost-in-use, reducing ingredient requirements per serving while creating room for other functional ingredients.

This combination of human evidence, substantiation, and formulation flexibility offers a different way to approach gut health innovation. Rather than competing for attention with another broad microbiome claim, brands can build products around evidence that gives both formulators and consumers greater confidence. 

Click here to explore the scientific evidence behind Bimuno GOS and its potential applications.

You may also like